Lab21 appoints group director
Of quality, regulatory affairs and operations excellence
Dr Logue worked for almost two decades in divisions of Abbott Laboratories. He was most recently division vice president World Wide Manufacturing for Abbott Diabetes Care, moving from division vice president European Operations. Prior to this he was operations director for Abbott Diagnostics Division Ireland, and director of Quality & Regulatory and marketing manager for Abbott Diagnostics Division in Germany.
Dr Logue said: ‘Lab21 has achieved remarkable progress within the past 4 years, growing five times in size. I am looking forward to contributing to its future success.’
You may also like
Analysis
UK biotech ends 2025 resilient as investor confidence returns, BIA reports
UK biotech finished 2025 with renewed momentum despite a challenging investment climate, according to the BioIndustry Association, with a strong Q4 rebound and growing policy support boosting confidence as the sector heads into 2026